As previously announced, the Board still believes that this assessment is without merit and maintains its position based on the legal advice received and independent reviews of the Group's systems. The Company continues to take all appropriate legal channels to challenge the assessment received.
Back to All News
All Market News
Other Market News
Greggs Release Q3 Trading Update
Goodwin – Trading Update
Renishaw – Final Results
Diageo Announce Directorate Change
AstraZeneca’s Trixeo Approved in EU for Asthma
B.P. Marsh – Trading Update
Sign up for our Stock News Highlights
Delivered to your inbox every Friday